GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
M

Microba Life Sciences MAP.AX · AUD

Health Care · ASX · 🇦🇺 Australia

Compare

0.03

—

Close of 9 Nov 2026, in AUD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Microba Life Sciences — daily ASX:MAP

No embeddable chart for this listing. TradingView's free widgets do not cover this exchange, and an unsupported symbol would render an error panel rather than a chart.

View Microba Life Sciences on TradingView ↗
Market value
A$20.7m
Last close × shares
Volume
70.4k
Shares, 9 Nov 2026

About Microba Life Sciences

Its shares trade on ASX under the ticker MAP.AX. It has been listed since 5 April 2022. In the fiscal year to 30 June 2025, it reported revenue of A$15.7m and a net loss of A$14.9m. At that date it held total assets of A$47.4m and shareholders' equity of A$32.5m.

Microba Life Sciences Ltd. analyzes the microbiome to discover novel therapeutics and develop new diagnostic tools. The company is headquartered in Brisbane, Queensland. The company went IPO on 2022-04-05. The firm is engaged in the discovery and development of therapeutics for major chronic diseases and delivers gut microbiome testing services globally to researchers, clinicians and consumers. The company offers a range of platforms, such as Analysis Platform, Discovery Platform and Therapeutic Platform. Through its analysis and discovery platforms, it identifies microbiome-derived therapeutics and diagnostic tools to advance medicine. The company provides precise and comprehensive measurements of the human gut microbiome. Through its Analysis Platform, it generates a global databank of microbiome samples and associated metadata to develop new health solutions. Its Discovery Platform enables partners to access this databank for the data-driven discovery of product opportunities. Its therapeutic platform is a repeatable platform for microbial therapeutic leads. The company has two segments: Testing Services, and Research & Development.

Figures and description from our data supplier, not checked against the company's own report.

More about Microba Life Sciences →

Latest on Microba Life Sciences

Our reporting

We have not reported on Microba Life Sciences yet.

Next results

3 Mar 2027

Due on 3 Mar 2027.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Microba Life Sciences's ticker?

Microba Life Sciences trades as MAP.AX on ASX, under ISIN AU0000209868.

What was Microba Life Sciences's last closing price?

0.03 on 9 Nov 2026. The figure is in AUD and is never converted.

When does Microba Life Sciences next report results?

Results are expected on 3 Mar 2027, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.